Effect of congestive heart failure on mexiletine pharmacokinetics in a Japanese population

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 11, 2006, Pages 2267-2269

  Kobayashi, Mariko ^a   Fukumoto, Kyoko ^a   Ueno, Kazuyuki ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

Clearance; Congestive heart failure; Mexiletine; New York Heart Association (NYHA)

Indexed keywords

MEXILETINE;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL PATIENT; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE;

ADMINISTRATION, ORAL; ANTI-ARRHYTHMIA AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INPATIENTS; MALE; METABOLIC CLEARANCE RATE; MEXILETINE; SEVERITY OF ILLNESS INDEX;

EID: 33750617583     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.2267     Document Type: Article

References (17)

1. Vaughan Williams E. M., J. Clin. Pharmacol., 24, 129-147 (1984).
2. Woosley R. L., Wang T., Stone W., Siddoway L., Thompson K., Duff H. J., Am. Heart J., 17, 158-165 (1984).
3. Chew C. Y. C., Collett J., Singh B. N., Drugs, 17, 161-181 (1979).
4. Campbell N. P. S., Kelley J. G., Adgey A. A. J., Shanks R. G., Br. J. Clin. Pharmacol., 6, 13-18 (1978).
5. Labbe L., Turgeon J., Clin. Pharmacokinet., 37, 361-384 (1999).
6. Vozeh S., Katz G., Steiner V., Follath F., Eur. J. Clin. Pharmacol., 23, 445-451 (1982).
7. Ueno K., Tamamura A., Matsumoto K., Komamura K., Kamakura S., Miyatake K., Shibakawa M., Ann. Pharamacother., 36, 241-245 (2002).
8. Belanger O. G., Gilbert M., Turgeon J., LeBlanc P. P., Clin. Pharmacol. Ther., 37, 638-643 (1985).
9. Mastropaolo W., Holmes D. R., Osborn M. J., Rooke J., Moyer T. P., Clin. Chem., 30, 319-322 (1984).
10. Uenaka K., Koue T., Iwai T., Shibakawa M., Ueno K., Biol. Pharm. Bull., 21, 844-846 (1998).
11. Shammas F. V., Dickstein K., Clin. Pharmacokinet., 15, 94-113 (1988).
12. Waller E. S., J. Clin. Pharmacol., 21, 191-194 (1981).
13. Turgeon J., Fiset C., Giguere R., Gilbert M., Moerike K., Rouleau J. R., Kroemer H. K., Eichelbaum. M., Grech-Belanger O., Belanger P. M., J. Pharmacol. Exp. Ther., 259, 789-798 (1991).
14. Vandamme N., Broly F., Libersa C., Courseau C., Lhermitte M., J. Cardiovasc. Pharmacol., 21, 77-83 (1992).
15. Kobayashi K., Nakajima M., Ciba K., Yamamoto T., Tani M., Ishizaki T., Kuroiwa Y., Br. J. Clin. Pharmacol., 45, 361-368 (1998).
16. Nakajima M., Kobayashi K., Shimada N., Tokudome S., Yamamoto T., Kuroiwa Y., Br. J. Clin. Pharmacol., 46, 55-62 (1998).
17. Maeda Y., Funakoshi S., Nakamura M., Fukuzawa M., Kugaya Y., Yamasaki M., Tsukiai S., Murakami T., Takano M., Clin. Pharamacol. Ther., 71, 389-397 (2002).